Quantitative proteomic analysis of EZH2 inhibition in acute myeloid leukemia reveals the targets and pathways that precede the induction of cell death
Jarrod J Sandow, Giuseppe Infusini, Aliaksei Z Holik, Gabriela Brumatti, Tessa V Averink, Paul G Ekert, Andrew I Webb
Proteomics Clinical Applications | WILEY-V C H VERLAG GMBH | Published : 2017
Awarded by NHMRC project
This work was supported by NHMRC project grants # 1025594, # 1081376. GB is supported by Victorian Cancer Agency, Mid-career fellowship. This work was made possible through Victorian State Government Operational Infrastructure Support, and L. E. W. Carty Charitable Fund and Ian Rollo Currie Estate Foundation for infrastructure support.